In addition to patients with IIMs with autoantibodies to TIF1-γ, NXP2 and SAE1, we also noted that in some cases in the anti-ARS group (anti-Jo-1 and anti-PL-12) there was temporally proximate occurrence of the cancer and myositis onset. This evidence concerns the gene SAE1 and cancer.